MORGAN STANLEY PLC/PUT/PFIZER INC/30/0.1/21.03.25 Stock

Warrant

DE000MB5SAL0

Market Closed - Börse Stuttgart 14:19:21 2024-07-03 EDT
0.36 EUR +2.86% Intraday chart for MORGAN STANLEY PLC/PUT/PFIZER INC/30/0.1/21.03.25
Current month+2.86%
1 month+28.57%
Date Price Change
24-07-03 0.36 +2.86%
24-07-02 0.35 +6.06%
24-07-01 0.33 -5.71%
24-06-28 0.35 -5.41%
24-06-27 0.37 -2.63%

Delayed Quote Börse Stuttgart

Last update July 03, 2024 at 02:19 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying PFIZER, INC.
Issuer Morgan Stanley
WKN MB5SAL
ISINDE000MB5SAL0
Date issued 2023-04-24
Strike 30 $
Maturity 2025-03-21 (261 Days)
Parity 10 : 1
Emission price 0.2
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 0.56
Lowest since issue 0.126
Spread 0.01
Spread %2.78%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
27.7 USD
Average target price
31.92 USD
Spread / Average Target
+15.22%
Consensus